{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:05:30Z","timestamp":1776384330375,"version":"3.51.2"},"reference-count":151,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY027802, EY028160, EY005722"],"award-info":[{"award-number":["EY027802, EY028160, EY005722"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Core Grant"],"award-info":[{"award-number":["Core Grant"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Vasculogenesis and angiogenesis are physiological mechanisms occurring throughout the body. Any disruption to the precise balance of blood vessel growth necessary to support healthy tissue, and the inhibition of abnormal vessel sprouting has the potential to negatively impact stages of development and\/or healing. Therefore, the identification of key regulators of these vascular processes is critical to identifying therapeutic means by which to target vascular-associated compromises and complications. Nuclear receptors are a family of transcription factors that have been shown to be involved in modulating different aspects of vascular biology in many tissues systems. Most recently, the role of nuclear receptors in ocular biology and vasculopathies has garnered interest. Herein, we review studies that have used in vitro assays and in vivo models to investigate nuclear receptor-driven pathways in two ocular vascular diseases associated with blindness, wet or exudative age-related macular degeneration, and proliferative diabetic retinopathy. The potential therapeutic targeting of nuclear receptors for ocular diseases is also discussed.<\/jats:p>","DOI":"10.3390\/ijms21082889","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T04:49:38Z","timestamp":1587444578000},"page":"2889","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases"],"prefix":"10.3390","volume":"21","author":[{"given":"Pei-Li","family":"Yao","sequence":"first","affiliation":[{"name":"Duke Eye Center, Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27503, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-364X","authenticated-orcid":false,"given":"Jeremy","family":"Peavey","sequence":"additional","affiliation":[{"name":"Duke Eye Center, Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27503, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goldis","family":"Malek","sequence":"additional","affiliation":[{"name":"Duke Eye Center, Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27503, USA"},{"name":"Department of Pathology, Duke University School of Medicine, Durham, NC 27503, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrm.2017.36","article-title":"Vascular heterogeneity and specialization in development and disease","volume":"18","author":"Potente","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kruger-Genge, A., Blocki, A., Franke, R.P., and Jung, F. (2019). Vascular Endothelial Cell Biology: An Update. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184411"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1387\/ijdb.103213sp","article-title":"Signal transduction in vasculogenesis and developmental angiogenesis","volume":"55","year":"2011","journal-title":"Int. J. Dev. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Naito, H., Iba, T., and Takakura, N. (2020). Mechanisms of new blood vessel formation and proliferative heterogeneity of endothelial cells. Int. Immunol.","DOI":"10.1093\/intimm\/dxaa008"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/01.ATV.0000232542.42968.e3","article-title":"Transcriptional regulators of angiogenesis","volume":"26","author":"Hamik","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","article-title":"Nuclear Receptors, RXR, and the Big Bang","volume":"157","author":"Evans","year":"2014","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12943-019-0971-9","article-title":"Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment","volume":"18","author":"Cheng","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1940-6207.CAPR-11-0528","article-title":"Nuclear receptors as modulators of the tumor microenvironment","volume":"5","author":"Sherman","year":"2012","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1530\/JME-16-0082","article-title":"Emerging functional roles of nuclear receptors in breast cancer","volume":"58","author":"Doan","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/me.2013-1291","article-title":"Minireview: Role of orphan nuclear receptors in cancer and potential as drug targets","volume":"28","author":"Safe","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","article-title":"Mechanisms of age-related macular degeneration","volume":"75","author":"Ambati","year":"2012","journal-title":"Neuron"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/opo.12675","article-title":"Risk factors for progression of age-related macular degeneration","volume":"40","author":"Heesterbeek","year":"2020","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_13","first-page":"2913612","article-title":"Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for Proteoglycans","volume":"2016","author":"Thach","year":"2016","journal-title":"J. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/CIA.S143508","article-title":"Recent developments in age-related macular degeneration: A review","volume":"12","author":"Yassin","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"ref_15","first-page":"8374647","article-title":"Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD","volume":"2018","author":"Zenteno","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1007\/s00018-014-1709-x","article-title":"Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration","volume":"71","author":"Malek","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00109-013-1007-3","article-title":"Inflammation and oxidative stress in angiogenesis and vascular disease","volume":"91","author":"Kim","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3389\/fphar.2019.01363","article-title":"Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction","volume":"10","author":"Yeo","year":"2019","journal-title":"Front Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"546826","DOI":"10.1155\/2010\/546826","article-title":"Inflammatory mediators and angiogenic factors in choroidal neovascularization: Pathogenetic interactions and therapeutic implications","volume":"2010","author":"Campa","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_20","first-page":"S172","article-title":"Review of neovascular age-related macular degeneration treatment options","volume":"25","author":"Holekamp","year":"2019","journal-title":"Am. J. Manag. Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e000398","DOI":"10.1136\/bmjophth-2019-000398","article-title":"Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: A comparative review","volume":"4","author":"Khanna","year":"2019","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"786870","DOI":"10.1155\/2012\/786870","article-title":"Anti-VEGF Treatment Strategies for Wet AMD","volume":"2012","author":"Kovach","year":"2012","journal-title":"J. Ophthalmol."},{"key":"ref_23","first-page":"1857","article-title":"Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: A comprehensive review","volume":"10","author":"Yang","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: A multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ophtha.2019.11.010","article-title":"Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert Opinion","volume":"127","author":"Sadda","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"18751","DOI":"10.1073\/pnas.0905010106","article-title":"An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris","volume":"106","author":"Kurihara","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1210\/me.2010-0392","article-title":"Research resource: Nuclear receptor atlas of human retinal pigment epithelial cells: Potential relevance to age-related macular degeneration","volume":"25","author":"Dwyer","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/1087057116659856","article-title":"Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases","volume":"21","author":"Choudhary","year":"2016","journal-title":"J. Biomol. Screen"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/me.2012-1010","article-title":"Minireview: The role of nuclear receptors in photoreceptor differentiation and disease","volume":"26","author":"Forrest","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"27603","DOI":"10.18632\/oncotarget.15178","article-title":"The association between nuclear receptors and ocular diseases","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"925309","DOI":"10.1155\/2009\/925309","article-title":"Cross-Talk between PPARs and the Partners of RXR: A Molecular Perspective","volume":"2009","author":"Chan","year":"2009","journal-title":"PPAR Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3214","article-title":"The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention","volume":"12","author":"Peters","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1874196700902010141","article-title":"Peroxisome Proliferator-Activated Receptor Expression in Murine Models and Humans with Age-related Macular Degeneration","volume":"2","author":"Herzlich","year":"2009","journal-title":"Open Biol. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.preteyeres.2004.06.002","article-title":"The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina","volume":"24","author":"SanGiovanni","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/archopht.126.6.826","article-title":"Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: A systematic review and meta-analysis","volume":"126","author":"Chong","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1167\/iovs.17-21796","article-title":"Adiponectin Mediates Dietary Omega-3 Long-Chain Polyunsaturated Fatty Acid Protection Against Choroidal Neovascularization in Mice","volume":"58","author":"Fu","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3945\/ajcn.114.099291","article-title":"Dietary omega-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin","volume":"101","author":"Fu","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ebiom.2016.09.025","article-title":"Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis","volume":"13","author":"Gong","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"SanGiovanni, J.P., Chen, J., Sapieha, P., Aderman, C.M., Stahl, A., Clemons, T.E., Chew, E.Y., and Smith, L.E. (2013). DNA sequence variants in PPARGC1A, a gene encoding a coactivator of the omega-3 LCPUFA sensing PPAR-RXR transcription complex, are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053155"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1167\/iovs.17-22091","article-title":"Therapeutic Effects of PPARalpha Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration","volume":"58","author":"Qiu","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_44","first-page":"2309","article-title":"Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization","volume":"41","author":"Murata","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"720163","DOI":"10.1155\/2008\/720163","article-title":"Prevention of Oxidative Stress-Induced Retinal Pigment Epithelial Cell Death by the PPARgamma Agonists, 15-Deoxy-Delta12,14-Prostaglandin J(2)","volume":"2008","author":"Chang","year":"2008","journal-title":"PPAR Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.ATV.0000250972.83623.61","article-title":"Activation of PPARbeta\/delta induces endothelial cell proliferation and angiogenesis","volume":"27","author":"Piqueras","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.07.010","article-title":"The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease","volume":"181","author":"Fessler","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2006.11.022","article-title":"Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma","volume":"25","author":"Ghisletti","year":"2007","journal-title":"Mol. Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e131928","DOI":"10.1172\/jci.insight.131928","article-title":"LXRs regulate features of age-related macular degeneration and may be a potential therapeutic target","volume":"5","author":"Choudhary","year":"2020","journal-title":"JCI Insight"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16507","DOI":"10.1073\/pnas.1904719116","article-title":"Retinal and optic nerve degeneration in liver X receptor beta knockout mice","volume":"116","author":"Song","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1167\/iovs.14-15612","article-title":"Activation of liver X receptor protects inner retinal damage induced by N-methyl-D-aspartate","volume":"56","author":"Zheng","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10456-018-9604-y","article-title":"Time-dependent LXR\/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization","volume":"21","author":"Mukwaya","year":"2018","journal-title":"Angiogenesis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1530\/JOE-14-0349","article-title":"Oestrogen, ocular function and low-level vision: A review","volume":"223","author":"Hutchinson","year":"2014","journal-title":"J. Endocrinol."},{"key":"ref_56","first-page":"923","article-title":"The role of estrogen and estrogen receptorbeta in choroidal neovascularization","volume":"10","author":"Tanemura","year":"2004","journal-title":"Mol. Vis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0161-6420(03)00495-0","article-title":"Incidence of exudative age-related macular degeneration among elderly Americans","volume":"110","author":"Javitt","year":"2003","journal-title":"Ophthalmology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: A meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.exer.2004.10.008","article-title":"Gender and estrogen supplementation increases severity of experimental choroidal neovascularization","volume":"80","author":"Hernandez","year":"2005","journal-title":"Exp. Eye Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1167\/iovs.06-0577","article-title":"Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder","volume":"48","author":"Boekhoorn","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/aje\/kwn024","article-title":"Study of Osteoporotic Fractures Research, G., Estrogen receptor alpha and matrix metalloproteinase 2 polymorphisms and age-related maculopathy in older women","volume":"167","author":"Seitzman","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09286580490907779","article-title":"Hormone replacement therapy, reproductive factors, and age-related macular degeneration: The Salisbury Eye Evaluation Project","volume":"12","author":"Freeman","year":"2005","journal-title":"Ophthalmic Epidemiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1167\/iovs.09-4000","article-title":"Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms","volume":"51","author":"Edwards","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0002-9394(02)01755-5","article-title":"Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women","volume":"134","author":"Snow","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/ICB.0000000000000549","article-title":"Hormonal Supplementation Triggering Choroidal Neovascularization in Healthy Young Females","volume":"13","author":"Domenech","year":"2019","journal-title":"Retin. Cases Br. Rep."},{"key":"ref_66","first-page":"197","article-title":"Role of aryl hydrocarbon receptor in cancer","volume":"1836","author":"Feng","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"25135","DOI":"10.1074\/jbc.M109.013292","article-title":"Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-A depletion in the endothelium and transforming growth factor-beta overexpression in the stroma","volume":"284","author":"Roman","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/path.4433","article-title":"Aryl hydrocarbon receptor knock-out exacerbates choroidal neovascularization via multiple pathogenic pathways","volume":"235","author":"Choudhary","year":"2015","journal-title":"J. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E4069","DOI":"10.1073\/pnas.1307574110","article-title":"Aryl hydrocarbon receptor deficiency causes dysregulated cellular matrix metabolism and age-related macular degeneration-like pathology","volume":"110","author":"Hu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bbadis.2018.02.015","article-title":"Suppression of aberrant choroidal neovascularization through activation of the aryl hydrocarbon receptor","volume":"1864","author":"Choudhary","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.steroids.2017.11.002","article-title":"Glucocorticoid receptor signaling in the eye","volume":"133","author":"Sulaiman","year":"2018","journal-title":"Steroids"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jsbmb.2019.01.009","article-title":"Glucocorticoid-mediated effects on angiogenesis in solid tumors","volume":"188","author":"Martens","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"ii6","DOI":"10.1093\/rheumatology\/kew348","article-title":"Glucocorticoids and chronic inflammation","volume":"55","author":"Straub","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: Mechanisms of Action in Health and Disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5679517","DOI":"10.1155\/2017\/5679517","article-title":"Crosstalk between Aryl Hydrocarbon Receptor and Glucocorticoid Receptor in Human Retinal Pigment Epithelial Cells","volume":"2017","author":"Jin","year":"2017","journal-title":"Int. J. Endocrinol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9898","DOI":"10.1038\/srep09898","article-title":"The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe","volume":"5","author":"Takata","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archopht.119.3.399","article-title":"Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model","volume":"119","author":"Ciulla","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/ICB.0000000000000592","article-title":"Dexamethasone Intravitreal Implant for Choroidal Neovascularization during Pregnancy","volume":"13","author":"Capuano","year":"2019","journal-title":"Retin. Cases Br. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/sj.eye.6703041","article-title":"Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation","volume":"22","author":"Bakri","year":"2008","journal-title":"Eye (Lond.)"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/IAE.0b013e3180323de7","article-title":"Triple therapy for choroidal neovascularization due to age-related macular degeneration: Verteporfin PDT, bevacizumab, and dexamethasone","volume":"27","author":"Augustin","year":"2007","journal-title":"Retina"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3129\/i09-243","article-title":"Triple therapy for neovascular age-related macular degeneration (verteporfin photodynamic therapy, intravitreal dexamethasone, and intravitreal bevacizumab)","volume":"45","author":"Ehmann","year":"2010","journal-title":"Can. J. Ophthalmol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/ciia.2006.1.3.237","article-title":"Anecortave acetate in the treatment of age-related macular degeneration","volume":"1","author":"Augustin","year":"2006","journal-title":"Clin. Interv. Aging"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.survophthal.2006.11.005","article-title":"Anecortave acetate for the treatment of exudative age-related macular degeneration\u2014A review of clinical outcomes","volume":"52","author":"Russell","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000431129","article-title":"Ocular Angiogenesis: Vascular Endothelial Growth Factor and Other Factors","volume":"55","author":"Rubio","year":"2016","journal-title":"Dev. Ophthalmol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.survophthal.2006.11.003","article-title":"Mechanism of action of the angiostatic cortisene anecortave acetate","volume":"52","author":"Clark","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Hong, F., Xu, P., and Zhai, Y. (2018). The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082189"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Age-Related Eye Disease Study Research Group (2000). Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology, 107, 2224\u20132232.","DOI":"10.1016\/S0161-6420(00)00409-7"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ophtha.2003.11.010","article-title":"Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents","volume":"111","author":"Tomany","year":"2004","journal-title":"Ophthalmology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ophtha.2004.08.012","article-title":"Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/OPTH.S119510","article-title":"Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: Results of a phase II randomized trial","volume":"11","author":"Gallemore","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157339909787314149","article-title":"Diabetic retinopathy and angiogenesis","volume":"5","author":"Crawford","year":"2009","journal-title":"Curr. Diabetes Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2337\/diacare.9.4.334","article-title":"Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota","volume":"9","author":"Ballard","year":"1986","journal-title":"Diabetes Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s40135-016-0098-8","article-title":"The Role of Systemic Risk Factors in Diabetic Retinopathy","volume":"4","author":"Atchison","year":"2016","journal-title":"Curr. Ophthalmol. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"ref_98","first-page":"801269","article-title":"Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets","volume":"2014","author":"Safi","year":"2014","journal-title":"Bio. Med. Res. Int."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"9702820","DOI":"10.1155\/2017\/9702820","article-title":"Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy","volume":"2017","author":"Li","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/ars.2008.2280","article-title":"PPARs and the cardiovascular system","volume":"11","author":"Hamblin","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.1073\/pnas.1307211110","article-title":"Pathogenic role of diabetes-induced PPAR-\u03b1 down-regulation in microvascular dysfunction","volume":"110","author":"Hu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1","volume":"274","author":"Delerive","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejphar.2012.10.012","article-title":"Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy","volume":"698","author":"Kadian","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Group","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.2337\/db13-0800","article-title":"An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes","volume":"62","author":"Noonan","year":"2013","journal-title":"Diabetes"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"904251","DOI":"10.1155\/2008\/904251","article-title":"The Role of PPARs in the Endothelium: Implications for Cancer Therapy","volume":"2008","author":"Swales","year":"2008","journal-title":"PPAR Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1167\/iovs.13-11608","article-title":"Peroxisome proliferator-activated receptor-\u03b2\/\u03b4 regulates angiogenic cell behaviors and oxygen-induced retinopathy","volume":"54","author":"Capozzi","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5381.2011.01443.x","article-title":"Is PPARG the key gene in diabetic retinopathy?","volume":"165","author":"Costa","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_112","first-page":"126917","article-title":"Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy","volume":"2009","author":"Costa","year":"2009","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.diabres.2007.11.001","article-title":"Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes","volume":"80","author":"Malecki","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jdiacomp.2014.10.010","article-title":"Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy","volume":"29","author":"Katome","year":"2015","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1167\/iovs.08-2005","article-title":"Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: Role of NADPH oxidase","volume":"50","author":"Tawfik","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ebiom.2017.07.008","article-title":"The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor","volume":"22","author":"Hammer","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17460441.2018.1430136","article-title":"Models of retinal diseases and their applicability in drug discovery","volume":"13","author":"Malek","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.2337\/db11-1596","article-title":"Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes","volume":"61","author":"Hazra","year":"2012","journal-title":"Diabetes"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Von Essen, M.R., and Geisler, C. (2018). VDR, the Vitamin D Receptor. Encyclopedia of Signaling Molecules, Springer International Publishing.","DOI":"10.1007\/978-3-319-67199-4_287"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1111\/bph.13875","article-title":"Vitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dre-miR-21 and VEGF","volume":"174","author":"Merrigan","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1152\/japplphysiol.00570.2009","article-title":"Rev-erb-alpha: An integrator of circadian rhythms and metabolism","volume":"107","author":"Duez","year":"2009","journal-title":"J. Appl. Physiol. (Bethesda Md. 1985)"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4155\/fmc.11.9","article-title":"The REV-ERBs and RORs: Molecular links between circadian rhythms and lipid homeostasis","volume":"3","author":"Solt","year":"2011","journal-title":"Future Med. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e001","DOI":"10.1621\/nrs.08001","article-title":"Nuclear receptor Rev-erbalpha: A heme receptor that coordinates circadian rhythm and metabolism","volume":"8","author":"Yin","year":"2010","journal-title":"Nucl. Recept. Signal."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1210\/me.2002-0384","article-title":"Activation functions 1 and 2 of nuclear receptors: Molecular strategies for transcriptional activation","volume":"17","author":"Treuter","year":"2003","journal-title":"Mol. Endocrinol. (Baltim. Md.)"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tem.2012.05.012","article-title":"Action of RORs and their ligands in (patho) physiology","volume":"23","author":"Solt","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/eji.201545712","article-title":"Nuclear hormone receptors put immunity on sterols","volume":"45","author":"Santori","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/hh2401.101755","article-title":"Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha","volume":"89","author":"Besnard","year":"2001","journal-title":"Circ. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.1073\/pnas.1504387112","article-title":"Nuclear receptor ROR\u03b1 regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation","volume":"112","author":"Sun","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","first-page":"4492","article-title":"ROR\u03b1 modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis","volume":"31","author":"Sun","year":"2017","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood-2012-04-422527","article-title":"SOCS3 is an endogenous inhibitor of pathologic angiogenesis","volume":"120","author":"Stahl","year":"2012","journal-title":"Blood"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI44900","article-title":"Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice","volume":"121","author":"Fukushima","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1101\/gad.2042011","article-title":"Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism","volume":"25","author":"Kim","year":"2011","journal-title":"Genes. Dev."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCRESAHA.109.210815","article-title":"Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis","volume":"106","author":"Moriya","year":"2010","journal-title":"Circu. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41467-017-00215-1","article-title":"ROR\u03b1 controls hepatic lipid homeostasis via negative regulation of PPAR\u03b3 transcriptional network","volume":"8","author":"Kim","year":"2017","journal-title":"Nature Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0014-5793(01)03275-6","article-title":"Expression and regulation of the nuclear receptor RORalpha in human vascular cells","volume":"511","author":"Besnard","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1172\/JCI80590","article-title":"Role of the circadian system in cardiovascular disease","volume":"128","author":"Thosar","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4161\/cc.23596","article-title":"Clock controls angiogenesis","volume":"12","author":"Jensen","year":"2013","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"ref_138","first-page":"1","article-title":"Circadian rhythms of angiogenic factors in skin and wound tissue in per2-mutant mice","volume":"2","author":"Hoshi","year":"2017","journal-title":"Biomed. Res. Clin. Pract."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/bmc-2014-0009","article-title":"Circadian angiogenesis","volume":"5","author":"Jensen","year":"2014","journal-title":"Biomol. Concepts"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1084\/jem.20090889","article-title":"Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock","volume":"206","author":"Busik","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_141","first-page":"965","article-title":"The multifaceted mineralocorticoid receptor","volume":"4","year":"2014","journal-title":"Compr. Physiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tem.2015.10.001","article-title":"Cardiac GR and MR: From Development to Pathology","volume":"27","author":"Richardson","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/db14-0670","article-title":"Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes","volume":"64","author":"Garg","year":"2015","journal-title":"Diabetes"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Tan","year":"2009","journal-title":"Circ. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/02713680500263598","article-title":"Glucocorticoid regulation of endothelial cell tight junction gene expression: Novel treatments for diabetic retinopathy","volume":"30","author":"Felinski","year":"2005","journal-title":"Curr. Eye Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jop.2008.0090","article-title":"Fluocinolone Inhibits VEGF Expression via Glucocorticoid Receptor in Human Retinal Pigment Epithelial (ARPE-19) Cells and TNF-\u03b1\u2013Induced Angiogenesis in Chick Chorioallantoic Membrane (CAM)","volume":"25","author":"Ayalasomayajula","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00125-001-0769-2","article-title":"Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy","volume":"45","author":"Taverna","year":"2002","journal-title":"Diabetologia"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1210\/jc.2004-2407","article-title":"Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes","volume":"90","author":"Taverna","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00592-006-0225-3","article-title":"Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients","volume":"43","author":"Cyganek","year":"2006","journal-title":"Acta Diabetol."},{"key":"ref_150","first-page":"99","article-title":"Retinopathy and nephropathy in type 1 diabetic patients\u2014Association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and IL-1 receptor 1 genes","volume":"33","author":"Zemunik","year":"2009","journal-title":"Coll. Antropol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.arcmed.2015.09.006","article-title":"Vitamin D Receptor Genetic Polymorphism Is Significantly Associated with Risk of Type 2 Diabetes Mellitus in Chinese Han Population","volume":"46","author":"Jia","year":"2015","journal-title":"Arch. Med. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/8\/2889\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:09:08Z","timestamp":1760364548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/8\/2889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":151,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ijms21082889"],"URL":"https:\/\/doi.org\/10.3390\/ijms21082889","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]}}}